+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Oncology Clinical Trials Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Oncology Clinical Trials Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 734 Pages
  • Global
From
Micafungin Sodium For Injection Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Micafungin Sodium For Injection Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 72 Pages
  • Global
From
LAMEA Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

LAMEA Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 77 Pages
  • Middle East, Africa
From
Asia Pacific Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Asia Pacific Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 77 Pages
  • Asia Pacific
From
Europe Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Europe Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 77 Pages
  • Europe
From
North America Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

North America Hearing Loss Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By End-user, By Country and Growth Forecast, 2022-2028

  • Report
  • January 2023
  • 69 Pages
  • North America
From
Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Protein Kinase C (PKC) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Protein Kinase C (PKC) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 322 Pages
  • Global
From
Genito Urinary Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Genito Urinary Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2022
  • 83 Pages
  • Global
From
Overactive Bladder - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Overactive Bladder - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 130 Pages
  • Global
From
Oral Anti-diabetes Drugs Market - Growth, Trends, and Forecasts (2020 - 2025) - Product Thumbnail Image

Oral Anti-diabetes Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

  • Report
  • August 2020
  • 150 Pages
  • Global
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Regenerative Therapies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Regenerative Therapies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • August 2024
  • 93 Pages
  • Global
From
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Genitourinary Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Genitourinary Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 52 Pages
  • Global
From
Bioinformatics Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Bioinformatics Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Loading Indicator